HAART during pregnancy and during breastfeeding among HIV-infected women in the developing world: has the time come?

Abstract

This editorial comment focuses upon the idea of offering HAART to all HIV-infected pregnant women including those in developing countries and considers the barriers or problems associated with this concept as well as the positive outcomes. It states that more data is needed but that a strategy would be to ensure that women with CD4 cell count below 350 cells/ml in resource-limited settings receive HAART that would then be continued after breastfeeding cessation for maternal health.